๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation

โœ Scribed by Maurizio Zangari; Bart Barlogie; Elias Anaissie; Fariba Saghafifar; Paul Eddlemon; Joth Jacobson; Choon-Kee Lee; Raymond Thertulien; Giampaolo Talamo; Teri Thomas; Frits Van Rhee; Athanasios Fassas; Louis Fink; Guido Tricot

Book ID
108672762
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
236 KB
Volume
126
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

P140 Prognostic impact of 1q21 amplifica
P140 Prognostic impact of 1q21 amplification in patients with multiple myeloma treated by velcade, thalidomide and any conventional chemotherapy
โœ P. Nemec; P. Kuglik; V. Vranova; R. Zaoralova; H. Greslikova; A. Oltova; H. Filk ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 47 KB

Conclusions: Among their pts with GI nHl the slow increase of incidence from all lymphoma cases, the slight decrease of MALT lymphomas, the elevation of cases of intestinal and of gastric lymphomas with high grade B-cell origin and at all, in this latter group the beneficial effect of rituximab+CHOP

Prophylactic recombinant erythropoietin
Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis
โœ Elias J. Anaissie; Elizabeth A. Coleman; Julia A. Goodwin; Robert L. Kennedy; Ki ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 186 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND: Venous thromboembolism (VTE) is a significant but poorly understood complication in patients with newly diagnosed multiple myeloma (NDMM). As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The purpose of this retrospective st